This federal Project Grant award, valued at $500,000.00 and awarded by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351), supports the development of human-based, connected multi-organ microphysiological system in vitro models to study alphavirus infection and support countermeasure development. The primary awardee is George Mason University, a large public research university in Fairfax, Virginia, which has a history of delivering scientific research, engineering, and technology development services to federal agencies through both contracts and grants. The university's expertise across multiple disciplines, including national security, healthcare, and environmental sciences, makes it a valuable partner for government initiatives. This five-year award, with a completion date of July 30, 2029, will contribute to advancing fundamental knowledge and capabilities to defend against potential chemical, biological, radiological, nuclear, and high-yield explosive threats.
Generated 3/25/25, 5:13 AM